In a significant leap forward for healthcare, AI-driven biotech startups are transforming the landscape of rare disease treatment by harnessing the power of automation, advanced data analysis, and gene editing technologies.

As showcased at the Web Summit Qatar, these innovative solutions are addressing the pressing issue of labor shortages in drug discovery, paving the way for an era where AI-driven technologies bridge the gaps and accelerate the development of life-saving treatments.

Photo by CDC on Pexels
Photos provided by Pexels